XML 29 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 7 - Investments
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Investment [Text Block]

NOTE 7 INVESTMENTS

 

The amortized cost, gross unrealized gains and losses included in accumulated other comprehensive (loss) income, and estimated fair value of the Company's available-for-sale investments at December 31, 2023 and December 31, 2022 are summarized in the tables shown below:

 

(in thousands)

 

December 31, 2023

 
      

Gross

  

Gross

     
  

Amortized

  

Unrealized

  

Unrealized

  

Estimated Fair

 
  

Cost

  

Gains

  

Losses

  

Value

 

Fixed maturities:

                

U.S. government, government agencies and authorities

 $13,384  $8  $395  $12,997 

States, municipalities and political subdivisions

  2,885   3   105   2,783 

Mortgage-backed

  9,724   23   494   9,253 

Asset-backed

  1,254   1   45   1,210 

Corporate

  10,860   18   648   10,230 

Total fixed maturities

 $38,107  $53  $1,687  $36,473 

 

(in thousands)

 

December 31, 2022

 
      

Gross

  

Gross

     
  

Amortized

  

Unrealized

  

Unrealized

  

Estimated Fair

 
  

Cost

  

Gains

  

Losses

  

Value

 

Fixed maturities:

                

U.S. government, government agencies and authorities

 $15,797  $  $717  $15,080 

States, municipalities and political subdivisions

  2,390      158   2,232 

Mortgage-backed

  9,058   1   647   8,412 

Asset-backed

  1,682      72   1,610 

Corporate

  11,200   1   944   10,257 

Total fixed maturities

 $40,127  $2  $2,538  $37,591 

 

The table below summarizes the Company's fixed maturities at December 31, 2023 by contractual maturity periods. Actual results may differ as issuers may have the right to call or prepay obligations, with or without penalties, prior to the contractual maturity of these obligations.

 

(in thousands)

 

December 31, 2023

 
      

Estimated Fair

 
  

Amortized Cost

  

Value

 

Due in one year or less

 $6,021  $5,922 

Due after one year through five years

  26,223   25,155 

Due after five years through ten years

  1,144   1,067 

Due after ten years

  4,719   4,329 

Total

 $38,107  $36,473 

 

 

The following tables highlight the aggregate unrealized loss position, by security type, of available-for-sale investments in unrealized loss positions where no credit loss allowance had been established as of December 31, 2023 and December 31, 2022. The tables segregate the holdings based on the period of time the investments have been continuously held in unrealized loss positions.

 

(in thousands)

                 

December 31, 2023

 
  

Less than 12 Months

  

Greater than 12 Months

  

Total

 
  

Estimated

  

Unrealized

  

Estimated

  

Unrealized

  

Estimated

  

Unrealized

 
  

Fair Value

  

Loss

  

Fair Value

  

Loss

  

Fair Value

  

Loss

 

Fixed maturities:

                        

U.S. government, government agencies and authorities

 $3,237  $46  $7,940  $349  $11,177  $395 

States, municipalities and political subdivisions

        1,705   105   1,705   105 

Mortgage-backed

  737   11   6,067   483   6,804   494 

Asset-backed

        1,050   45   1,050   45 

Corporate

  937   11   8,013   637   8,950   648 

Total fixed maturities

 $4,911  $68  $24,775  $1,619  $29,686  $1,687 

 

(in thousands)

                 

December 31, 2022

 
  

Less than 12 Months

  

Greater than 12 Months

  

Total

 
  

Estimated

  

Unrealized

  

Estimated

  

Unrealized

  

Estimated

  

Unrealized

 
  

Fair Value

  

Loss

  

Fair Value

  

Loss

  

Fair Value

  

Loss

 

Fixed maturities:

                        

U.S. government, government agencies and authorities

 $4,543  $126  $10,537  $591  $15,080  $717 

States, municipalities and political subdivisions

  1,040   73   937   85   1,977   158 

Mortgage-backed

  2,248   93   5,756   554   8,004   647 

Asset-backed

  1,251   39   299   33   1,550   72 

Corporate

  3,244   155   6,760   789   10,004   944 

Total fixed maturities

 $12,326  $486  $24,289  $2,052  $36,615  $2,538 

 

At December 31, 2023, there are approximately 181 individual available-for-sale investments that were in unrealized loss positions, for which an allowance for credit losses had not been recorded.  The Company did not have the intent to sell these investments, and it was not more likely than not that the Company would be required to sell these investments before recovery of its amortized cost. The Company evaluated these investments for credit losses at December 31, 2023. The Company considers many factors in evaluating whether the unrealized losses were credit-related, including, but not limited to, the extent to which the fair value has been less than amortized cost, conditions related to the security, industry, or geographic area, payment structure of the investment and the likelihood of the issuer’s ability to make contractual cashflows, defaults or other collectability concerns related to the issuer, changes in the ratings assigned by a rating agency, and other credit enhancements that affect the investment’s expected performance. The Company determined that the unrealized losses on the fixed maturity investments were due to non-credit related factors at December 31, 2023.

 

At  December 31, 2022, there are approximately 208 individual available-for-sale investments that were in unrealized loss positions. Prior to the adoption of ASU 2016-13, the Company performed an analysis of the individual investments to determine if declines in market value were other-than-temporary.  The Company reviewed currently available information, including, but not limited to, the credit ratings of the issuers of the investments in the fixed maturities with estimated fair values less than their carrying amounts and believes these unrealized losses are not other-than-temporary and are primarily due to temporary market and sector-related factors rather than to issuer-specific factors. The Company did not have the intent to sell these investments, and it was not more likely than not that the Company would be required to sell those investments before recovery of its amortized cost.

 

The establishment of an impairment loss on an investment requires a number of judgments and estimates. The Company performs a quarterly analysis of the individual investments for factors that may indicate a decline in fair value below its cost, amortized cost or modified cost. Refer to the "Significant Accounting Policies and Critical Estimates" section of Management's Discussion & Analysis for further information regarding the Company's detailed analysis and factors considered in recording an impairment loss on an investment.

 

The Company did not record any write-downs for impairment related to available-for-sale fixed maturity investments for the years ended December 31, 2023 and December 31, 2022

 

The Company does not have any exposure to subprime mortgage-backed investments.

 

As of December 31, 2023 and December 31, 2022, the carrying value of limited liability investments totaled $0.8 million and $1.0 million, respectively.  The Company recorded impairments related to limited liability investments of $0.1 million and zero for the years ended  December 31, 2023 and December 31, 2022, respectively, which are included in impairment losses in the consolidated statements of operations.  At December 31, 2023, the Company has no unfunded commitments related to limited liability investments.  

 

 

Limited liability investments, at fair value represents the underlying investments of the Company’s consolidated entities Argo Holdings and Net Lease (at December 31, 2022 only).  As of December 31, 2023 and December 31, 2022, the carrying value of the Company's limited liability investments, at fair value was $3.5 million and $17.1 million, respectively.  The Company recorded impairments related to limited liability investments, at fair value of $0.1 million and less than $0.1 million for the years ended  December 31, 2023 and December 31, 2022, respectively, which are included in gain (loss) on change in fair value of limited liability investments, at fair value in the consolidated statements of operations. At  December 31, 2023, the Company has no unfunded commitments related to limited liability investments, at fair value.

 

The Company consolidated the financial statements of Net Lease on a three-month lag. Net Lease owned investments in limited liability companies that held investment properties. 

 

 

During the fourth quarter of 2022, one of Net Lease's limited liability companies refinanced their existing debt.  Debt proceeds of $5.2 million were distributed to Net Lease, which decreased Net Lease's investment in the limited liability company, which the Company recorded during the first quarter of 2023. 

 

During the first quarter of 2023, Net Lease sold its final investment property for $15.8 million.  Net Lease received net proceeds of $8.1 million after the repayment of debt at the limited liability company and transaction expenses.  

 

As a result of the sale and subsequent distribution of the net proceeds, the carrying value of Net Lease's investments in limited liability companies is zero at  December 31, 2023. 

 

As of December 31, 2023 and December 31, 2022, the carrying value of the Company’s investments in private companies totaled $0.9 million and $0.8 million. For the years ended December 31, 2023 and December 31, 2022, the Company recorded adjustments of $0.1 million and zero, respectively, to increase the fair value of certain investments in private companies for observable price changes, which are included in unrealized gain on private company investments in the consolidated statements of operations.

 

The Company performs a quarterly impairment analysis of its investments in private companies. As a result of the analysis performed, the Company did not record any impairments related to investments in private companies for the years ended December 31, 2023 and December 31, 2022.

 

Real estate investments represented investment real estate properties held by the Company’s consolidated subsidiary, Flower.  On September 29, 2022, Flower sold their investment real estate properties for $12.2 million.  A portion of the proceeds from the sale were used to repay the Flower note payable with an unpaid principal balance of $5.9 million at the transaction date.  Flower recorded a gain of $1.5 million related to the sale, which is included in gain on change in fair value of real estate investments in the consolidated statement of operations for the year ended December 31, 2022.  

 

Net investment income for the years ended December 31, 2023 and December 31, 2022, respectively, is comprised as follows:

 

(in thousands)

 

Years ended December 31,

 
  

2023

  

2022

 

Investment income

        

Interest from fixed maturities

 $1,018  $556 

Dividends

  97   159 

(Loss) income from limited liability investments

  (44)  293 

Income from limited liability investments, at fair value

     4 

Income from real estate investments

     795 

Other

  839   612 

Gross investment income

  1,910   2,419 

Investment expenses

  (106)  (114)

Net investment income

 $1,804  $2,305 

 

Net realized gains on investments for the years ended December 31, 2023 and December 31, 2022 are comprised as follows:

 

(in thousands)

 

Years ended December 31,

 
  

2023

  

2022

 

Available-for-sale fixed maturities:

        

Gross realized gains

 $9  $2 

Gross realized losses

  (6)  (25)

Net realized gains (losses) on available-for-sale fixed maturities

  3   (23)

Limited liability investments

  238   366 

Limited liability investments, at fair value

  481   608 

Investments in private companies

  39   258 

Net realized gains

 $761  $1,209 

 

Net gain (loss) on equity investments for the years ended December 31, 2023 and December 31, 2022 is comprised as follows:

 

(in thousands)

 

Years ended December 31,

 
  

2023

  

2022

 

Net gains recognized on equity investments sold during the period

 $3,383  $ 

Change in unrealized gains (losses) on equity investments held at end of the period

  14   (26)

Net gain (loss) on equity investments

 $3,397  $(26)

 

 

Prior to the second quarter of 2023, the Company held 400,000 warrants in Limbach Holdings, Inc. ("Limbach").  During the first quarter of 2023, the underlying common stock price of Limbach increased, resulting in an increase in the fair value of the warrants held at March 31, 2023.  During the second quarter of 2023, the Company completed a cashless exercise of its Limbach warrants and received 110,036 shares of Limbach common stock.  During the third quarter of 2023, the Company sold all of its Limbach common shares.  The Company recorded total gains related to Limbach of $3.3 million during the year ended  December 31, 2023.